I
ilumed
Helping other healthcare organizations transition to value-based care models
About ilumed
Based in Jupiter, Florida, ilumed operates as a Medicare transformation company, established in 2018 to navigate the shift towards value-based healthcare. The company was founded by CEO Debra Finnel, a healthcare industry veteran with four decades of experience in managed care and MSO leadership, who identified an opportunity to improve care delivery for the senior population. ilumed functions as an Accountable Care Organization (ACO) within the federal ACO REACH (Realizing Equity, Access, and Community Health) model, which evolved from the Direct Contracting program. This model financially incentivizes healthcare providers for delivering high-quality, cost-effective care to traditional Medicare beneficiaries.
The company's business model centers on creating partnerships with a range of healthcare providers—from solo practitioners to large health systems—to manage the complexities of value-based arrangements. Ilumed provides its partners with the necessary tools, technology, and support to succeed under a shared savings model, where providers can earn revenue above the standard Medicare fee schedule by meeting specific quality and cost targets. This approach aims to create financial stability for physicians while improving patient outcomes. For its services, ilumed has secured significant funding, including a $16.5 million Series A round in December 2021, led by Ascend Partners, and a subsequent $20 million debt financing in May 2024, bringing its total raised capital to over $86 million.
Ilumed’s core service offering revolves around its proprietary data analytics platform, BrainStream, which provides a comprehensive health profile of each patient by aggregating medical history, lab results, and prescriptions. This technology enables providers to identify at-risk patients, manage population health, and prevent costly hospital admissions by addressing potential issues proactively. Beyond technology, ilumed provides extensive wraparound services, including care coordination, patient outreach, and support for social determinants of health (SDoH) like transportation to appointments and meal delivery. This hands-on support for both providers and patients has yielded notable results, including achieving a 100% quality score from CMS and generating over $30 million in medical cost savings in 2022. The company has demonstrated rapid growth, expanding from serving 24,000 beneficiaries in four states in 2022 to over 56,000 across ten states in 2023.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Dec 2021 | $17M | $66M | Ascend Capital Partners · Ascend Partners | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for ilumed is 3.3K monthly website visits, up 65% over the last three months. ilumed's team declined 13% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Ascend Partners
Ascend Capital Partners
Other known investors1 additional known investor
CRG
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about ilumed on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ilumed’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






